PRECISION BIOLOGIC INC

Precision Biologic Inc. specializes in the manufacturing of biological products within the pharmaceutical and life sciences sector, operating under NAICS 325413 for pharmaceutical preparation. The company’s core capabilities center on the development and production of biologics, including sterile formulations, aseptic processing, and controlled-environment manufacturing systems compliant with cGMP standards. Technical expertise includes bioreactor operations, purification chromatography, lyophilization, and analytical method validation for protein-based therapeutics. Their operational focus emphasizes process scalability, batch consistency, and quality control systems aligned with FDA and Health Canada regulatory frameworks. Precision Biologic Inc. differentiates itself through precision manufacturing protocols and closed-system handling techniques critical for high-potency and cell-based products. No agency award history is available to characterize specific government relationships or programmatic work. Consequently, there is no verifiable pattern of engagement with federal departments or defense, health, or research agencies. The company’s primary industry focus is pharmaceutical manufacturing, specifically the production of biologics for clinical and commercial use. This includes monoclonal antibodies, vaccines, and recombinant proteins requiring stringent environmental controls and validation protocols. Their market positioning is that of a niche contract manufacturer serving regulated biopharmaceutical markets, with an emphasis on quality-driven production rather than R&D or distribution. Precision Biologic Inc. is structured as a small business entity under code X6 and is headquartered in Dartmouth, Nova Scotia. The company holds no active government certifications such as 8(a), HUBZone, or SDVOSB. Its geographic presence is localized to Atlantic Canada, with operations focused on domestic and potentially international biopharma supply chains. The business operates as a specialized manufacturer within the broader life sciences ecosystem, leveraging regional expertise in biotechnology manufacturing without federal contracting visibility.